Eric Laille (E Laille)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 6

Top Topics

Acute Myeloid Leukemia

Top Venues

Leukemia & lymphoma

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical pharmacology and therapeutics

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Allison Gaudy, Eric Laille, Rochelle Bailey, Simon Zhou, Barry Skikne, C L Beach
Population pharmacokinetics of oral azacitidine, and exposure-response analysis in acute myeloid leukemia. Clinical pharmacology and therapeutics (2023)
Stéphane de Botton, Pau Montesinos, Andre Schuh, Cristina Papayannidis, Paresh Vyas, Andrew H Wei, Hans Beier Ommen, Sergey Semochkin, Hee-Je Kim, Richard A Larson, Jamie Koprivnikar, Olga Frankfurt, Felicitas R Thol, Jörg Chromik, Jenny L Byrne, Arnaud Pigneux, Xavier Thomas, Olga Salamero, María-Belén Vidriales, Vadim A Doronin, Hartmut Döhner, Amir T Fathi, Eric Laille, Xin Yu, Maroof Hasan, Patricia Martín-Regueira, Courtney D D DiNardo
Enasidenib vs conventional care in mutant-IDH2 relapsed/refractory acute myeloidleukemia: a randomized, phase 3 trial. Blood (2022)
Guillermo Garcia Manero, Valeria Santini, Antonio Almeida, Uwe Platzbecker, Anna Jonasova, Lewis R Silverman, Jose Falantes, Gianluigi Reda, Francesco Buccisano, Pierre Fenaux, Rena Buckstein, Maria Diez Campelo, Stephen Larsen, David Valcarcel, Paresh Vyas, Valentina Giai, Esther Natalie Oliva, Jake Shortt, Dietger Niederwieser, Moshe Mittelman, Luana Fianchi, Ignazia La Torre, Jianhua Zhong, Eric Laille, Daniel Lopes de Menezes, Barry Skikne, C L Beach, Aristoteles Giagounidis
Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (13) (2021)
Roisin M Connolly, Eric Laille, Ulka Vaishampayan, Vincent Chung, Karen Kelly, Afshin Dowlati, Olatunji B Alese, Robert Donald Harvey, Paul Haluska, Lillian L Siu, Shivaani Kummar, Richard Piekarz, S Percy Ivy, Nicole M Anders, Melinda Downs, Ashley O'Connor, Angela Scardina, Jacqueline Saunders, Gary L Rosner, Michelle A Rudek, null null
Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (20) (2020)
A G E Beer, Eric Laille, H Neuwirt, G Mayer, R Stauder
Azacitidine is removed effectively by hemodialysis. Leukemia & lymphoma 62 (3) (2020)
Xin Du, Yue-Yun Lai, Zhijian Xiao, Ting Liu, Yu Hu, Aining Sun, Xiao Li, Zhi-Xiang Shen, Jie Jin, Li Yu, Eric Laille, Qian Dong, Stephen Songer, C L Beach
Efficacy, safety and pharmacokinetics of subcutaneous azacitidine in Chinese patients with higher risk myelodysplastic syndromes: Results from a multicenter, single-arm, open-label phase 2 study. Asia-Pacific journal of clinical oncology 14 (3) (2017)